Skip to main content

IDEX Biometrics: Employee Share Purchase Plan Share Issue – 1 September 2021

The board of directors of IDEX Biometrics ASA has resolved to issue 913,198 ordinary shares at NOK 2.10 per share to employees who participate in the company’s 2020 Employee Share Purchase Plan (2020 ESPP), which plan was approved by the annual general meeting on 15 May 2020.

53 employees participated in the 2020 ESPP in this cycle. The participating employees have elected to invest a part of the base salary in ordinary shares in the company. Purchase takes place every three months. The shares are restricted for three months.

Following the issue, the Company’s share capital will be NOK 137,926,078.20 divided into 919,507,188 shares each with a nominal value of NOK 0.15.

Primary insiders
IDEX discloses transactions by the following primary insiders in IDEX shares ISIN NO0003070609:
–   CEO Vince Graziani acquired 20,490 ordinary shares at NOK 2.10 per share.
–   CTO Anthony Eaton acquired 8,029 ordinary shares at NOK 2.10 per share.

IDEX 2020 ESPP
The 2020 ESPP was approved at the annual general meeting on 15 May 2020. Reference is made to the notice of said meeting where the plan document in connection with the 2020 ESPP is attached. 

All employees in the Company and its subsidiaries, except in China, have been offered to subscribe for shares in the Company in connection with the ESPP. The 2020 ESPP is structured around four contribution periods a year, each starting on the first day of the calendar month following each planned disclosure of an interim report of the Company and lasts for the following three months. During each contribution period, a fixed amount (up to 20% of the employee’s gross base salary) is withheld from the employee’s net salary. The employee may sign up to participate in the ESPP from the date of a public disclosure of an interim report until the beginning of the contribution period. Unless the employee actively withdraws from the ESPP, participation is automatically renewed for the same amount for subsequent contribution periods. The board’s resolution to issue new shares in connection with the ESPP is made pursuant to the authorization granted by the Company’s annual general meeting on 15 May 2020 to increase the Company’s share capital in connection with the ESPP. The 2020 ESPP is now closed for further contributions and purchases.

In accordance with the ESPP, the subscription price is the lower closing price of the Company’s share, as traded on Oslo Børs, on the first or last day of the contribution period, less 15% discount. Payment of the subscription amount is made out of the relevant employee salary withholding.

In accordance with Regulation (EU) 2017/1129 (the “Prospectus Regulation”) Article 1 (5) h, issuance of shares in connection with the ESPP is exempt from the obligation to publish a listing prospectus.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings. We invent, engineer, and commercialize these secure and safe yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.